Resolutions passed at the Extraordinary General Meeting in Orphazyme A/S
(WorldNews Finland)

Orphazyme A/S Decisions of general meeting Resolutions passed at the Extraordinary General Meeting in Orphazyme A/S Orphazyme A/S Company announcement No. 05/2020 Company Registration No. 32266355 Copenhagen, Denmark, January 25, 2020 - Orphazyme A/S (ORPHA.CO), a biopharmaceutical company pioneering Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases, today held an Extraordinary General Meeting, at which the shareholders passed the following resolutions: To amend the current Article 3.4 of the Articles of Association pursuant to which the Board of Directors in the period until January 25, 2025 is authorized to increase the Company`s share capital in one or...